AGIO icon

Agios Pharmaceuticals
AGIO

Overview Fund Activity

185 hedge funds and large institutions have $1.81B invested in Agios Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 62 increasing their positions, 57 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
185
Holders Change
+17
Holders Change %
+10.12%
% of All Funds
2.68%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
40
Increased
62
Reduced
57
Closed
23
Calls
$12.5M
Puts
$15.5M
Net Calls
-$3.02M
Net Calls Change
-$1.92M

Top Buyers

1
FCM
1
Farallon Capital Management
California
$163M
2
GKIM
2
GW&K Investment Management
Massachusetts
$19M
3
State Street
3
State Street
Massachusetts
$91.8M
4
Assenagon Asset Management
4
Assenagon Asset Management
Luxembourg
$13.3M
5
PBA
5
Paradigm Biocapital Advisors
New York
$11.7M

Top Sellers

1
First Trust Advisors
1
First Trust Advisors
Illinois
$0
2
DTC
2
Deep Track Capital
Connecticut
$0
3
AC
3
Armistice Capital
New York
$86.7M
4
RSCM
4
Rock Springs Capital Management
Maryland
$51.6M
5
SCM
5
Suvretta Capital Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
A
201
AlphaQuest
New York
– -$41.5K -1,863 Closed
AF
202
Advisornet Financial
Minnesota
– -$34.1K -1,532 Closed
Group One Trading
203
Group One Trading
Illinois
– -$23K -1,035 Closed
ASN
204
Advisory Services Network
Georgia
– -$7.8K -350 Closed
GWS
205
Glassman Wealth Services
Virginia
– -$2.23K -100 Closed
GI
206
Gradient Investments
Minnesota
– -$490 -22 Closed
DPW
207
DiNuzzo Private Wealth
Pennsylvania
– -$23 -1 Closed
5 6 7 8
9